Lyra Therapeutics, Inc. ( LYRA) - Stock Earnings
Stock symbol LYRA is outdated, potentially delisted? Maybe it is available on other exchange?
LYRA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 17, 2026, midnight | — / — | — | — / — | — |
LYRA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q1 | -8.5 million USD | 183000 USD |
| 2025Q2 | -7.4 million USD | 183000 USD |
| 2025Q3 | -6.0 million USD | 25000 USD |
LYRA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -55.3 million USD | 1.4 million USD |
| 2023 | -62.7 million USD | 1.6 million USD |
| 2024 | -93.4 million USD | 1.5 million USD |
LYRA
Price: $0.73
52 week price:
Earnings Per Share: -22.90 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 10913
Market Capitalization: 878566